Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

AMLXAMLX
18 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in AMYLYX PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 2.3M shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $41.9M as of 2026-Q2. The position was increased (+5.6% shares). AMLX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$41.9M

Current Shares

2.3M

Total Value Change

+$39.5M

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+5.6%
$41.9M0.0%$17.96
31
2026-Q1
Increased
2.2M
+2.1%
$30.7M0.0%$14.11
29
2025-Q4
Increased
2.2M
+19.5%
$26.2M0.0%$12.00
34
2025-Q3
Increased
1.8M
+7.1%
$24.6M0.0%$14.90
31
2025-Q2
Increased
1.7M
+109.9%
$10.9M0.0%$6.33
45
2025-Q1
Increased
806,161
+42.0%
$2.9M0.0%$3.66
35
2024-Q4
Increased
567,903
+3.1%
$2.1M0.0%$3.84
27
2024-Q3
Increased
551,039
+17.5%
$1.8M0.0%$3.08
30
2024-Q2
Decreased
468,866
-56.0%
$891,0920.0%$1.90
0
2024-Q1
Increased
1.1M
+3.5%
$3M0.0%$2.84
27
2023-Q4
Increased
1M
+5.0%
$15.2M0.0%$14.72
30
2023-Q3
Increased
982,068
+4.7%
$18M0.0%$18.31
30
2023-Q2
Increased
937,997
+5.3%
$20.2M0.0%$20.98
30
2023-Q1
Increased
890,982
+4.3%
$26.1M0.0%$27.71
30
2022-Q4
Increased
853,913
+34.4%
$31.6M0.0%$36.95
37
2022-Q3
Increased
635,556
+174.6%
$17.9M0.0%$30.19
46
2022-Q2
Increased
231,417
+21.7%
$4.5M0.0%$18.18
32
2022-Q1
New
190,150
-
$2.4M0.0%$14.93
36

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used